Finance

Lists
Q1 2027 earnings • released • EPS beat +3.89% • Revenue miss -0.16%
See results
STE:NYSE
Steris PLC
$237.47
+2.45%
(+5.69) 1D
$237.47
0.00% (0.00)
After hours
Closed: Aug 7, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STE...
Open
$229.40
High
$238.45
Low
$227.42
Mkt. cap
23.14B
Avg. vol.
789.65K
Volume
804.02K
Dividend
1.16%
Quarterly dividend
$0.69
Ex-dividend date
Sep 4, 2026
P/E ratio
29.96
52-wk high
$269.44
52-wk low
$195.14
EPS
$7.93
Beta
0.91
Shares outstanding
97.46M
No. of employees
18K
Open
$229.40
High
$238.45
Low
$227.42
Mkt. cap
23.14B
Avg. vol.
789.65K
Volume
804.02K
Dividend
1.16%
Quarterly dividend
$0.69
Ex-dividend date
Sep 4, 2026
P/E ratio
29.96
52-wk high
$269.44
52-wk low
$195.14
EPS
$7.93
Beta
0.91
Shares outstanding
97.46M
No. of employees
18K
News stories
From sources across the web
Profile
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018. Steris is listed on the New York Stock Exchange, and is a constituent of the S&P 500 Index. As of 2024, the president and CEO is Daniel A. Carestio. Wikipedia
About Steris PLC
CEODan Carestio
Employees17.9K
Founded1985
Headquarters-
SectorMedical device
Websitehealthcare.steris.com
Analyst ratings
Based on 4 analysts giving stock ratings to STE in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for STE in the last 3 months.
Highest
Current $237.47
$275.00 (+15.80%)
Average
$271.33 (+14.26%)
Lowest
$269.00 (+13.28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Wood
UBS
Buy
Reiterated
$270.00
+13.7%
08/07/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/06/2026
Jason Bednar
Piper Sandler
Buy
Reiterated
$275.00
+15.8%
08/07/2026
Brett Fishbin
KeyBanc
Buy
Reiterated
$269.00
+13.3%
05/13/2026
Last report
Aug 6, 2026
Fiscal period
Q1 2027
EPS / Est. (USD)
$2.59 / $2.49
+3.89%beat
Revenue / Est. (USD)
1.49B / 1.50B
-0.16%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.46B
1.50B
1.59B
1.49B
Cost of goods sold
815.40M
841.00M
890.60M
807.60M
Cost of revenue
815.40M
841.00M
890.60M
807.60M
Research and development expenses
28.20M
29.50M
28.80M
28.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
348.40M
349.00M
350.70M
369.70M
Operating expense
376.60M
378.50M
379.50M
398.30M
Total operating expenses
1.19B
1.22B
1.27B
1.21B
Operating income
268.30M
276.70M
318.30M
286.80M
Other non operating income
-
-3.40M
-300.00K
400.00K
EBT including unusual items
253.10M
257.90M
304.50M
273.50M
EBT excluding unusual items
255.80M
261.30M
305.90M
274.50M
Income tax expense
60.60M
63.50M
84.20M
72.50M
Effective tax rate
23.94%
24.62%
27.65%
26.51%
Other operating expenses
-
-
-
-
Net income
191.90M
192.90M
220.20M
200.10M
Net profit margin
13.14%
12.89%
13.86%
-
Earnings per share
2.47
2.53
2.83
2.59
Interest and investment income
2.40M
2.90M
3.00M
3.10M
Interest expense
-14.90M
-14.90M
-15.10M
-15.80M
Net interest expenses
-12.50M
-12.00M
-12.10M
-12.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
389.70M
398.60M
442.20M
352.10M
Gain or loss from assets sale
400.00K
3.20M
-300.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps